Interferon inhibitory activity (IIA) is a logical candidate for explaining neutralizing antibody-negative partial responsiveness to interferon beta in multiple sclerosis (MS), but its role has not been evaluated.
Department of Cell and Molecular Biology, Roswell Park Cancer Institute, Jacobs Neurological Institute, , Buffalo, New York 14263, USA. Kailash.Chadha@RoswellPark.org